Ajinomoto has developed a Cypress-derived compound called hinokitiol to replace transferrin — the glycoprotein responsible for 95% of cultivated meat's manufacturing costs — potentially accelerating the industry's path to price parity with conventional meat.
Japanese food giant Ajinomoto has reportedly developed a patent-pending technology that replaces transferrin, the single most expensive component in cultivated meat production, with hinokitiol: a compound extracted from Cypress trees. The breakthrough, as reported by Green Queen, could meaningfully shrink the price gap between cultivated and conventional meat.
The conventional wisdom in the cultivated meat space has been that scaling recombinant protein production is the clearest route to cost parity. Ajinomoto's approach suggests a different path: skip recombinant transferrin altogether and find a cheaper, chemically stable molecule that performs the same biological job.
Transferrin is a glycoprotein that transports iron into cells, supporting viability, growth, and differentiation in cell culture. It's expensive because it's used at high concentrations. According to the Good Food Institute, transferrin and albumin together account for roughly 95% of the costs associated with manufacturing cultivated meat, a figure that has defined the industry's cost problem for years.
Ajinomoto's solution reportedly swaps that expensive protein for hinokitiol, a low-molecular-weight compound found in the wood of Cypress trees. The compound binds iron and delivers it into cells, effectively mimicking transferrin's core function. It is also reportedly listed on Japan's existing food additives list, which confirms its safety for human consumption.
There's a quality angle worth flagging. High-molecular-weight transferrin is prone to batch-to-batch variation, a headache for any manufacturer trying to standardise a food product. Green Queen reports that hinokitiol, being chemically stable, is expected to help stabilise the quality of serum-free media in addition to cutting costs.
The company says its technology has reportedly completed prototype testing, with market introduction planned within the next several years. That timeline matters because consumers have made their price sensitivity clear. A European survey found that a majority of respondents said they wouldn't buy cultivated meat if it were priced higher than its conventional counterpart.
Ajinomoto's move fits into a broader wave of cultivated meat cost-reduction work — industry reports suggest dramatic drops in production costs over the past decade, with recent media-cost breakthroughs announced by companies including Gourmey, Meatly, and BioCraft Pet Nutrition. The field is converging on the same insight: until media costs fall, cultivated meat can't compete on shelf. And that convergence frames the real question for the plant-based and sustainability space: the cultivated meat industry's bottleneck has always been biology crashing into economics, and a Cypress-derived compound that could knock out a significant portion of media costs isn't a silver bullet — but it addresses the specific lever that has kept these products stuck in pilot-scale purgatory. Whether cultivated meat can get cheap enough, fast enough, to actually displace industrial animal agriculture at meaningful volume remains an open question. Ajinomoto's bet is that the answer runs through a tree.
